RFI Employee Retirement Income Security Act (ERISA)

March 15, 2024

The Honorable Virginia Foxx
Committee on Education and the Workforce
U.S. House of Representatives
2176 Rayburn House Office Building
Washington DC 20515

Dear Chairwoman Foxx,

The American Society of Gene and Cell Therapy (ASGCT) welcomes the opportunity to respond to your request for information on the Employee Retirement Income Security Act (ERISA). ASGCT is a nonprofit professional membership organization comprised of more than 6,200 scientists, physicians, patient advocates, and other professionals. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, and biotechnology and pharmaceutical companies. Many of our members have spent their careers in this field performing the underlying research that has led to today’s robust pipeline of transformative therapies.

A core portion of ASGCT’s mission is to advance the discovery and clinical application of genetic and cellular therapies to alleviate human disease. To that end, ASGCT supports policies that foster the adoption of, and patient access to, new therapies, which thereby encourage continued development of these innovative treatments.

If you have questions about any of the information provided below, please contact Margarita Valdez Martínez, Director of Policy and Advocacy, at mvaldez@asgct.org.

Sincerely,

David Barrett, JD
Chief Executive Officer
American Society of Gene & Cell Therapy